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Background: Muscle injury is common and is thought to account for 10%–50% of all sports-related injuries. The
use of rest, ice, compression, and elevation is common in clinical practice, but many treatments over a long period
are required to produce a therapeutic effect. We evaluated the utility of photodynamic therapy as a new treatment
option for the acute stage of muscle injury.
Methods: Twenty 8-week-old Sprague-Dawley male rats underwent experimental injury of the right gastrocnemius
muscle with a drop-mass method. After muscle injury was induced, a liposomally formulated indocyanine green
derivative (7 mg/kg) near-infrared laser irradiation was performed at 18 h after injury. Local time-dependent changes in
the treatment (n = 14) and no treatment (n = 14) groups were evaluated with in vivo imaging, histologic examination,
and enzyme-linked immunosorbent assay methods.
Results: In vivo imaging fluorescence values were significantly higher in the no treatment group, whereas interleukin-6
and tumor necrosis factor-α levels were significantly higher in the treatment group at 18 h after injury. Histologic
examination results revealed that the treatment group had less bleeding and more degeneration repair processes
than the no treatment group at 24 h and 1 week after muscle injury.
Conclusions: These findings suggest that photodynamic therapy promotes a tissue-repairing effect during the early
stage of muscle injury.
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Muscle injuries are common and reportedly account for
10%–50% of all sports-related injuries [1]. These injuries
occur when the muscle fibers are damaged by external
pressure, often during contact sports such as football,
rugby, and American football. Muscle injuries most
commonly occur on the frontal surface of the thigh.
The so-called rest, ice, compression, and elevation
(RICE) treatment is the most popular acute-phase treat-
ment in clinical practice. However, previous magnetic
resonance imaging (MRI)-based studies have shown that* Correspondence: kazuhideinage@yahoo.co.jp
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required to produce a therapeutic effect [2]. While echo
assessments have shown that the pressure in a local
hematoma is controlled, the appropriate treatment
duration is unknown, and the acute period of treatment
has not been sufficiently established [3]. Importantly, in-
appropriate treatment in the early phase of muscle injury
results in chronic pain in approximately 30% of patients
[4]. Therefore, appropriate treatment in the early phase
is considered critical for the prevention of the transition
to chronic pain. However, the treatment efficacy may
depend on the severity of the injury.
Recent muscle pain assessments have revealed import-
ant roles for cytokines during the transition from the
acute to the chronic pain phase. Photodynamic therapy ishis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Photodynamic therapy. (A) Injecting a light-sensitive substance (photosensitizer) into a biologic body. (B) Irradiating the target body
tissue with light at a particular wavelength range and evolving active oxygen from the light-sensitive substances.
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inflammation, which involves injecting a light-sensitive
substance (photosensitizer) into a biologic body, irradiat-
ing the target body tissue with light at a particular wave-
length and evolving active oxygen from light-sensitive
substances (Figure 1). In particular, near-infrared fluores-
cent dye-bounded lipid, which tends to readily accumulate
in the fragile vasculature of tissues affected by tumors and
inflammation, has attracted attention as an effective local
treatment option [2,3,5-13]. Indeed, a Japanese study has
reported the effectiveness of this treatment for cancer [7];
Japanese National Health Insurance covers the treatment
for early cancers of the esophagus, stomach, and otherFigure 2 Drop-mass method. (A) Schematic representation of the impact ap
an acrylic guide tube. The weight was dropped onto an impacter, dividing thareas. However, while many studies have reported the use of
this procedure for tumor therapy, reports on its use for in-
flammation, as in the case of muscle injury, are lacking.
Therefore, the purpose of the present study was to evaluate
the use of photodynamic therapy as a new treatment option
for inflammation caused bymuscle injury.
Methods
All animal procedures and protocols were approved by
the ethics committees of Chiba University, and followed
the National Institutes of Health Guidelines for the Care
and Use of Laboratory Animals (1996 revision). We used
28 8-week-old Sprague-Dawley male rats. The body weightparatus. (B) A 115-g weight was dropped from a height of 1 m through
e muscle belly without injuring the overlying skin.
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injury. Before inducing the injury, all of the rats were anes-
thetized with ethyl ether. If a withdrawal reflex occurred,
additional anesthesia was administered until no response
was noted. The muscle injuries were induced without mak-
ing a skin incision. Experimental injury of the right gastro-
cnemius muscle was achieved by a drop-mass method [14].
A 115-g mass was dropped from a height of 1 m onto the
medial gastrocnemius muscle of the right leg (Figure 2). The
gastrocnemius muscle of the left leg was used as the control
site. A liposomally formulated indocyanine green derivative
(LP-iDOPE, 7mg/kg, Figure 3) was injected intraperitoneally
after the muscle injury was induced. Eighteen hours after
injury, near-infrared laser irradiation (light-emitting diode
(LED) device, 810 nm; power, 0.1 W/cm2; irradiation time,
30 s; Figure 4) was used to activate the photosensitive dye
within the right gastrocnemius. As detailed below, we com-
pared the local time-dependent changes between the treat-
ment (n = 14) and no treatment (n = 14) groups using three
methods described below.Experiment 1: in vivo imaging
We used an in vivo imaging system (In-Vivo FX PRO;
BRUKER Corporation, Billerica, MA, USA) to visuallyFigure 3 Schematic structure of the liposomally formulated indocyanine gevaluate fluorescence values in the two groups at the
muscle injury site (right side) at 12, 18, and 24 h after
injury (Figure 5). The near-infrared fluorescence in vivo
imaging system was equipped with an LED that emit-
ted light at a near-infrared wavelength of 760 nm, a
charge-coupled device (CCD) as an image detector, and
an optical high-pass filter placed in front of the CCD to
efficiently detect fluorescence signals. In addition, this
system consisted of a camera unit, a controller that oper-
ated the camera unit, and a remote controller that
controlled the LED intensity, video gain, and offset. The
fluorescence image was sent to a digital video processor
to be displayed on a television monitor in real time.Experiment 2: enzyme-linked immunosorbent assay
Inflammatory mediators in the two groups were ana-
lyzed at 18 h after muscle injury. Resected gastrocne-
mius muscle samples were frozen in liquid nitrogen,
pulverized or homogenized, and digested in a tissue lysis
reagent. Tumor necrosis factor (TNF)-α and interleukin
(IL)-6 production at the muscle injury site were quantified
using an enzyme-linked immunosorbent assay in accord-
ance with the manufacturer’s protocols (R&D Systems,
Minneapolis, MN, USA). Tissue protein levels were assayedreen derivative, designated as LP-iDOPE.
Figure 4 Near-infrared laser irradiation system (light-emitting diode (LED) device, 810 nm; power, 0.1 W/cm2; irradiation time, 30 s). (A) LED
device. (B) Covering the LED except the targeting spot. (C) Irradiation to the rat at 18 h after muscle injury.
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(Bio-Rad, Hercules, CA, USA), and inflammatory mediator
levels were normalized to tissue protein levels.
Experiment 3: histologic examination
The muscle injury sites (right side) of the two groups
were dissected from the hind limbs under anesthesia
with sodium pentobarbital (40 mg/kg, intraperitoneally)
at 12, 18, 24 h and 1 week (nine rats; three rats per time
period) after the muscle injury and perfused transcar-
dially with 0.9% saline followed by 500 mL of 4% para-
formaldehyde in phosphate buffer (0.1 M, pH 7.4). Each
formalin-fixed tissue specimen was embedded in paraf-
fin after dehydration for 14 h using an ascending series
of ethanol in Tissue-Tek VIP (M1500; Sakura Finetek
Japan Co. Ltd., Tokyo, Japan). Sections with a thickness
of 4 μm were prepared from these paraffin blocks using
a sliding microtome (LS113; Yamato-Kohki Industrial
Co. Ltd., Saitama, Japan) and were stuck on a glass slide
(#5116; Muto Pure Chemicals Co. Ltd., Tokyo, Japan).
These sections were stained with Mayer’s hematoxylinFigure 5 In vivo imaging system (In-Vivo FX PRO; BRUKER Corporation,
Billerica, MA, USA).(Muto Pure Chemicals Co. Ltd.) for 5 min after depar-
affinization with xylene and ethanol. After washing
with distilled water, these sections were dipped in 0.1%
ammonium solution several times and washed again,
and then washed using 100% ethanol. They were then
stained with 1% eosin & phloxine-equivalent solution
for 20 s. Finally, the sections were covered with mount-
ing medium (Entellan- New; Merck KGaA, Darmstadt,
Germany) after dehydration with a series of ethanol and
xylene. The slides were observed under a microscope
(BH20; Olympus Corporation, Tokyo, Japan) by a pro-
fessional animal pathologist, and the degree of each
finding was evaluated semiquantitatively. We evaluated
the presence or absence of histologic degeneration,
bleeding, and neutrophil recruitment in each slice. We
also compared the histologic changes between the treat-
ment and no treatment groups.
Statistical analysis
Fluorescence values at the muscle injury site were com-
pared between the two groups at 12, 18, and 24 h after
muscle injury using Student’s t test. Levels of inflamma-
tory mediators at the muscle injury site were compared
between the two groups at 18 h after the muscle injury




The average in vivo imaging fluorescence values at the
muscle injury site of the treatment group were 14,128,
18,193, and 12,429 pixel intensity at 12, 18, and 24 h after
injury, respectively. The average in vivo imaging fluores-
cence values at the muscle injury site of the no treatment
group were 14,847, 24,375, and 12,834 pixel intensity at 12,
18, and 24 h after injury, respectively. There were no signifi-
cant differences between the 12- and 24-h fluorescence
values in either group (12 h, P = 0.780; 24 h, P = 0.416).
However, the fluorescence value at 18 h after injury in the
Figure 7 Interleukin-6 levels in the muscle injury site at 18 h after
muscle injury in the treatment and no treatment groups.
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the treatment group (P = 0.020, Figure 6). These results
indicate that 18 h after injury, and immediately after photo-
dynamic therapy, the fluorescent brightness was signifi-
cantly decreased in the treatment group compared to that
in the no treatment group, suggesting the onset of the a
therapeutic effect.
Enzyme-linked immunosorbent assay
IL-6 (Figure 7) and TNF-α (Figure 8) levels were signifi-
cantly higher in the treatment group at 18 h after muscle
injury than in the no treatment group (TNF-α, P = 0.001;
IL-6, P = 0.002). In other words, irritable cytokines were
significantly increased in the treatment group compared
to the no treatment group at 18 h after muscle injury and
immediately after intervention.
Histologic evaluation
Local evaluation after staining of the samples with
hematoxylin & eosin at 24 h after injury (Figure 9) indi-
cated that the degeneration of tissue was higher in the no
treatment group than in the treatment group. Regarding
hematoma, the treatment group had almost no bleeding
between the muscle bundles, and only a small amount
of bleeding in the large breakage hiatus, while the no
treatment group showed a greater amount of bleeding. In
addition, sparse aggregates of neutrophils were found in the
treatment group, whereas the aggregates were dense in
the crush-wounded muscle fibers, along with fibroblasts, in
the no treatment group. Granulation was strongly recog-
nized in the treatment group compared to that in the non-
treatment group during the first week after muscle strain.Discussion
In this study, we used in vivo fluorescence imaging to
evaluate local fluorescent brightness after muscle injury
and found that the fluorescence signal was significantlyFigure 6 Average fluorescence values in the treatment and no
treatment groups using the in vivo imaging system.decreased in the treatment group compared to that in the
no treatment group at 18 h after injury. According to a pre-
vious report, photodynamic therapy has a local hemostatic
effect, such as neovascular vessel regression [15]. Indeed,
irradiation of LP-iDOPE causes the transformation of local
triplet oxygen to singlet oxygen and free radicals; local cel-
lular and tissue damage then occurs, and the local cells that
line the blood vessels become damaged and block the blood
vessel by creating a neovascular vessel [16]. In actual clin-
ical practice, this mechanism of action is widely used in the
ophthalmologic field for age-associated macular degener-
ation [6]. Our in vivo fluorescent findings are in line with
this proposed mechanism of action.
The levels of two key cytotoxins reflect the inflammation
and repair processes inmuscle injury [9-11,17,18]. TNF-α is
known not only as an irritable cytokine but also as an
apoptosis-inducing factor (repair-starting signal) [8]. In
addition, previous reports have indicated that IL-6 plays a
central role in inflammation and is involved in the repair
and growth of the deepmuscle [12]. Thus, increases in irrit-
able cytokine levels are important in the repair of injured
tissue. We found that the levels of irritable cytokines
significantly increased in the treatment group comparedFigure 8 Tumor necrosis factor-α levels in the muscle injury site at
18 h after muscle injury in the treatment and no treatment groups.
Figure 9 Hematoxylin and eosin staining of local tissues. Transverse sections showing gastrocnemius muscular fibers. (A) No injury site (100×).
(B) Treatment site at 24 h (100×). (C)No treatment site at 24 h (100×). (D) Treatment site at 24 h (400×). (E) No treatment site at 24 h (400×).
(F) No injury site (100×). (G) Treatment site at 1 week (100×).
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immediately after photodynamic therapy.
Additionally, histologic evaluations at 24 h after injury
demonstrated low bleeding and enhanced degeneration
repair processes in the treatment group. In addition, the
repair reaction for degeneration tended to be very active
even during the first week after muscle strain.
One limitation of this study is that we did not conduct
objective tissue evaluation (i.e., grading for damage). In
addition, we did not assess the maximum depth reached by
the treatment method. Since these two criteria can be im-
portant for the clinical application of photodynamic ther-
apy, we plan to examine them further in the future.
The LP-iDOPE used in this study was a liposomal prep-
aration including ICG as a fluorescent dye. Although no
reports have been published on the clinical use of this agent,the side effects are considered to be the same as those for
ICG. ICG is a relatively safe trial drug with few side effects,
but side effects (36/21,278 administration cases) were re-
ported in 0.17% of cases in previous studies. The primary side
effects reported were shock symptoms (0.02%: five cases),
nausea/vomiting (0.08%: 16 cases), angialgia (0.04%: eight
cases), and fever/heat sensations (0.02%: four cases) [19-21].
Conclusions
In conclusion, these findings suggest that photodynamic
therapy promotes cytokine-mediated processes. We there-
fore suggest that photodynamic therapy elicits a tissue-
repairing effect during the early stage of injury. Overall,
these findings suggest that photodynamic therapy is a bene-
ficial new treatment method for the acute period after
muscle injury.
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